GlassScriptPhysician profile
Michael Anthony Snover
NPI 1932738457
$812.67
in general payments reported to CMS, 2019-2025
8 companies · $64.22 in 2025
The $64.22 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.95 · 2022: $88.11 · 2023: $73.71 · 2024: $574 · 2025: $64.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415 · Travel and Lodging: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.29 |
| Travel and Lodging | $296.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $578.84 | 2023-2024 | Xeomin |
| Abbvie INC. | $71.49 | 2022-2024 | |
| Dendreon Pharmaceuticals LLC | $47.25 | 2022 | |
| Electronic Waveform Lab, INC. | $44.19 | 2025 | |
| Coloplast Corp | $24.61 | 2023 | Speedicath |
| Acera Surgical, INC. | $20.03 | 2025 | Restrata Wound Matrix |
| Abc Home Medical Supply, INC. | $13.31 | 2024 | |
| Penumbra, INC. | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Snover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.